Chassagne et al., 2004 - Google Patents
A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune libraryChassagne et al., 2004
- Document ID
- 10159816373642957269
- Author
- Chassagne S
- Laffly E
- Drouet E
- Hérodin F
- Lefranc M
- Thullier P
- Publication year
- Publication venue
- Molecular immunology
External Links
Snippet
Tetanus toxoid was used as a model antigen for the immunization of Macaca fascicularis. Using peripheral blood as a template, specific Fab-encoding genes were amplified by PCR on the fourth day after the final boost, and cloned in a phagemidic vector (pComb3X) as a …
- 230000035693 Fab 0 title abstract description 36
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parola et al. | Integrating high‐throughput screening and sequencing for monoclonal antibody discovery and engineering | |
| Chassagne et al. | A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library | |
| DK2683736T3 (en) | METHODS AND REAGENTS FOR CREATING MONOCLONAL ANTIBODIES | |
| Lee et al. | Insights into the chicken IgY with emphasis on the generation and applications of chicken recombinant monoclonal antibodies | |
| RU2562163C2 (en) | Libraries of synthetic polypeptides and methods of obtaining versions of polypeptides with natural diversity | |
| US9062305B2 (en) | Generation of human de novo pIX phage display libraries | |
| JP5685274B2 (en) | Mixture of binding proteins | |
| US20180134807A1 (en) | Complex-specific antibodies and antibody fragments and its use | |
| Kobayashi et al. | Two-step in vitro antibody affinity maturation enables estradiol-17β assays with more than 10-fold higher sensitivity | |
| CN102216328A (en) | Antigen binding polypeptides | |
| US9090994B2 (en) | Antibody humanization by framework assembly | |
| Rojas et al. | Phage antibody fragments library combining a single human light chain variable region with immune mouse heavy chain variable regions | |
| Zarebski et al. | Llama single domain antibodies as a tool for molecular mimicry | |
| Chen et al. | Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens | |
| Nelson et al. | A universal phage display system for the seamless construction of Fab libraries | |
| Sepulveda et al. | Design and testing of PCR primers for the construction of scFv libraries representing the immunoglobulin repertoire of rats | |
| Kim et al. | Guided selection of human antibody light chains against TAG-72 using a phage display chain shuffling approach | |
| Jacobin et al. | Human IgG monoclonal anti-αIIbβ3-binding fragments derived from immunized donors using phage display | |
| EP3394256B1 (en) | A method of generating an antibody naïve library, said library and application(s) thereof | |
| Chiliza et al. | Single-chain antibody fragments from a display library derived from chickens immunized with a mixture of parasite and viral antigens | |
| Houimel | The analysis of VH and VL genes repertoires of Fab library built from peripheral B cells of human rabies virus vaccinated donors | |
| Diebolder et al. | Generation of “LYmph Node Derived Antibody Libraries”(LYNDAL) for selecting fully human antibody fragments with therapeutic potential | |
| JP7337850B2 (en) | ANTIBODY LIBRARY AND ANTIBODY SCREENING METHOD USING THE SAME | |
| CN103588876A (en) | Method used for producing humanized antibodies or antigen combination fragments | |
| Padoa et al. | Engineered antibodies: A new tool for use in diabetes research |